These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 33296708)
1. YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer. Lo Sardo F; Pulito C; Sacconi A; Korita E; Sudol M; Strano S; Blandino G Cancer Lett; 2021 Mar; 500():51-63. PubMed ID: 33296708 [TBL] [Abstract][Full Text] [Related]
2. MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer. Lo Sardo F; Forcato M; Sacconi A; Capaci V; Zanconato F; Di Agostino S; Del Sal G; Pandolfi PP; Strano S; Bicciato S; Blandino G Carcinogenesis; 2017 Jan; 38(1):64-75. PubMed ID: 27797825 [TBL] [Abstract][Full Text] [Related]
3. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Kim M; Kim T; Johnson RL; Lim DS Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714 [TBL] [Abstract][Full Text] [Related]
5. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer. Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858 [TBL] [Abstract][Full Text] [Related]
6. TGF-β-SMAD-miR-520e axis regulates NSCLC metastasis through a TGFBR2-mediated negative-feedback loop. Kucuksayan H; Akgun S; Ozes ON; Alikanoglu AS; Yildiz M; Dal E; Akca H Carcinogenesis; 2019 Jul; 40(5):695-705. PubMed ID: 30475986 [TBL] [Abstract][Full Text] [Related]
7. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667 [TBL] [Abstract][Full Text] [Related]
9. Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524 [TBL] [Abstract][Full Text] [Related]
10. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer. Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196 [TBL] [Abstract][Full Text] [Related]
11. MiR-4319 hinders YAP expression to restrain non-small cell lung cancer growth through regulation of LIN28-mediated RFX5 stability. Yang Y; Li H; Liu Y; Chi C; Ni J; Lin X Biomed Pharmacother; 2019 Jul; 115():108956. PubMed ID: 31096145 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of YAP, TAZ, TEAD4 and p73 in human laryngeal cancer. Tsinias G; Nikou S; Mastronikolis N; Bravou V; Papadaki H Histol Histopathol; 2020 Sep; 35(9):983-995. PubMed ID: 32378727 [TBL] [Abstract][Full Text] [Related]
13. MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis. Kim J; Kwon H; Shin YK; Song G; Lee T; Kim Y; Jeong W; Lee U; Zhang X; Nam G; Jeung HC; Kim W; Jho EH Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13529-13540. PubMed ID: 32482852 [TBL] [Abstract][Full Text] [Related]
14. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer. Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427 [TBL] [Abstract][Full Text] [Related]
16. YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators. Hoxha S; Shepard A; Troutman S; Diao H; Doherty JR; Janiszewska M; Witwicki RM; Pipkin ME; Ja WW; Kareta MS; Kissil JL Cancer Res; 2020 Jun; 80(12):2512-2522. PubMed ID: 32409309 [TBL] [Abstract][Full Text] [Related]
17. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539 [TBL] [Abstract][Full Text] [Related]
18. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ. Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399 [TBL] [Abstract][Full Text] [Related]
19. Endothelin Promotes Colorectal Tumorigenesis by Activating YAP/TAZ. Wang Z; Liu P; Zhou X; Wang T; Feng X; Sun YP; Xiong Y; Yuan HX; Guan KL Cancer Res; 2017 May; 77(9):2413-2423. PubMed ID: 28249901 [TBL] [Abstract][Full Text] [Related]
20. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]